Replies to post #3470 on GW Pharmaceuticals Plc ADS (GWPH)

[emergingbiotechs]

There are dietary supplements and nutraceuticals that might do it as in Hemp Cannabidiol and or Cannabinoids but as far as a drug GWPH is it :-)

Highlights

Summary numbers: Revenues of USD 13.33 million, Net Earnings of USD -33.10 million, and Earnings per Share (EPS) of USD -1.58.
Gross margins widened from 91.56% to 91.64% compared to the same quarter last year, operating (EBITDA) margins now -176.88% from -91.17%.
Year-on-year change in operating cash flow of -1,012.72% is about the same as the change in earnings, likely no significant movement in accruals or reserves.
Narrowing of operating margins contributed to decline in earnings.

[emergingbiotechs]

GWPH be on alert tomorrow. GWPH Sativex is the first natural cannabis plant derivative to gain full market approval in any country.